Literature DB >> 1540534

Pharmacological implications of interleukin-5 in the control of eosinophilia.

C J Sanderson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1540534     DOI： 10.1016/s1054-3589(08)60965-5

Source DB:  PubMed          Journal:  Adv Pharmacol        ISSN： 1054-3589


× No keyword cloud information.
  4 in total

1.  The carboxy-terminal region of human interleukin-5 is essential for maintenance of tertiary structure but not for dimerization.

Authors:  A E Proudfoot; S C Brown; P Graber; F Talabot; C Y Arod; M C Peitsch; M Banks; M McKinnon; R Solari; T N Wells
Journal:  J Protein Chem       Date:  1996-07

2.  Monomeric isomers of human interleukin 5 show that 1:1 receptor recruitment is sufficient for function.

Authors:  J Li; R Cook; M L Doyle; P Hensley; D E McNulty; I Chaiken
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

Review 3.  Clinical overview of cutaneous features in hypereosinophilic syndrome.

Authors:  Sabine Gisela Plötz; Bettina Hüttig; Birgit Aigner; Christian Merkel; Knut Brockow; Cezmi Akdis; Ulf Darsow; Johannes Ring
Journal:  Curr Allergy Asthma Rep       Date:  2012-04       Impact factor: 4.806

4.  Efficacy of Astaxanthin for the Treatment of Atopic Dermatitis in a Murine Model.

Authors:  Yoko Yoshihisa; Tsugunobu Andoh; Kenji Matsunaga; Mati Ur Rehman; Takashi Maoka; Tadamichi Shimizu
Journal:  PLoS One       Date:  2016-03-29       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.